Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2017-03-01 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2017
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 28/2/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, share options, warrants, convertibles, and other share-related transactions for Guangdong Tannery Limited. The content focuses on share capital changes and related securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements, not a full financial report or announcement of voting results. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2017-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2017
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/1/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month. The document length is about 14,692 characters, indicating a detailed report rather than a brief announcement. Given the nature of the content, it fits best under 'Share Issue/Capital Change' (SHA) category, which covers announcements regarding new share issues, stock splits, or other capital changes.
2017-02-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2016
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2016, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's capital structure and share issuance activities during the month. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory filing reporting monthly share capital movements rather than a full financial report or announcement of a report. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is substantial (over 14,000 characters), indicating it is the report itself, not just an announcement.
2017-01-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2016
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/11/2016. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements to the Hong Kong Exchanges and Clearing Limited. The document is not an annual or interim report, earnings release, or management discussion. It is a specific regulatory disclosure about share capital movements, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2016-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2016
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other share-related transactions for the month ended 31/10/2016. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements, which aligns with the category of Regulatory Filings (RNS) as it does not fit into more specific categories like Capital/Financing Update (CAP) or Share Issue/Capital Change (SHA) because it is a routine monthly return rather than a specific announcement of a capital change event. The document length is substantial (over 14,000 characters), indicating it is a full report rather than a brief announcement. Therefore, the best classification is Regulatory Filings (RNS).
2016-11-02 English
Unaudited Financial Information for the nine months ended 30 September 2016
Interim / Quarterly Report Classification · 95% confidence The document is an announcement titled 'UNAUDITED FINANCIAL INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2016' by Guangdong Tannery Limited. It provides detailed financial highlights, including revenue, loss attributable to shareholders, total assets, and shareholders' equity for the nine months ended 30 September 2016, with comparative figures for 2015. The document explicitly states that the financial information is unaudited and based on internal records and management accounts, and it cautions that it has not been reviewed or audited by auditors. The content includes substantive financial data and analysis for a period shorter than a full fiscal year (nine months), which fits the definition of an Interim / Quarterly Report (IR). The document is 6745 characters long, which is sufficient to be a report rather than a brief announcement or publication notice. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2016
2016-10-28 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.